Cargando…
Role of Suppressor of Cytokine Signaling-1 In Murine Atherosclerosis
BACKGROUND: While the impact of inflammation as the substantial driving force of atherosclerosis has been investigated in detail throughout the years, the influence of negative regulators of pro-atherogenic pathways on plaque development has remained largely unknown. Suppressor of cytokine signaling...
Autores principales: | Grothusen, Christina, Schuett, Harald, Hillmer, Anja, Lumpe, Stefan, Grote, Karsten, Ballmaier, Matthias, Bleich, Andre, Glage, Silke, Tietge, Uwe J. F., Luchtefeld, Maren, Schieffer, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531439/ https://www.ncbi.nlm.nih.gov/pubmed/23300554 http://dx.doi.org/10.1371/journal.pone.0051608 |
Ejemplares similares
-
Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion
por: Oberoi, Raghav, et al.
Publicado: (2016) -
Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease
por: Oberoi, Raghav, et al.
Publicado: (2015) -
Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis
por: Vlacil, Ann-Kathrin, et al.
Publicado: (2020) -
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
por: Luchtefeld, Maren, et al.
Publicado: (2007) -
Experimental Gingivitis Induces Systemic Inflammatory Markers in Young Healthy Individuals: A Single-Subject Interventional Study
por: Eberhard, Jörg, et al.
Publicado: (2013)